Correlation Between Salesforce and BB Biotech
Specify exactly 2 symbols:
By analyzing existing cross correlation between Salesforce and BB Biotech AG, you can compare the effects of market volatilities on Salesforce and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and BB Biotech.
Diversification Opportunities for Salesforce and BB Biotech
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Salesforce and BBZA is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Salesforce i.e., Salesforce and BB Biotech go up and down completely randomly.
Pair Corralation between Salesforce and BB Biotech
Considering the 90-day investment horizon Salesforce is expected to generate 1.37 times more return on investment than BB Biotech. However, Salesforce is 1.37 times more volatile than BB Biotech AG. It trades about 0.23 of its potential returns per unit of risk. BB Biotech AG is currently generating about 0.07 per unit of risk. If you would invest 29,801 in Salesforce on September 3, 2024 and sell it today you would earn a total of 3,198 from holding Salesforce or generate 10.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Salesforce vs. BB Biotech AG
Performance |
Timeline |
Salesforce |
BB Biotech AG |
Salesforce and BB Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salesforce and BB Biotech
The main advantage of trading using opposite Salesforce and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
BB Biotech vs. Tyson Foods | BB Biotech vs. AUSTEVOLL SEAFOOD | BB Biotech vs. HF FOODS GRP | BB Biotech vs. Cal Maine Foods |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |